{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:9058"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:9058","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Regulation of suppressor of cytokine signalling-3 expression by cyclic-AMP in pro-myeloid cells","abstract":"Suppressors of cytokine signalling (SOCS) protein induction via the \"Janus kinase- signal transducer and activator of transcription\" (JAK-STAT) pathway has been shown to be a critical negative feedback mechanism that prevents inappropriately sustained signalling from activated cytokine receptors. It also provides a mechanism by which other signalling modules could potentially regulate the JAK-STAT pathway. In this study, I have demonstrated that elevation of the prototypical second messenger cyclic AMP (cAMP) is capable of promoting the time- and concentration-dependent accumulation of the SOCS-3 isoform in U937 human promyeloid cells and HL60 human promyoblast cells. Experiments with MG132 demonstrated that cAMP specifically promoted SOCS-3 synthesis rather than blocking its degradation by the proteasome. The accumulation of SOCS-3 in U937 cells correlated with a reduced ability of the granulocyte-colony stimulating factor (G-CSF) receptor, which is a bona fide target for SOCS-3 in vivo, to promote the Tyr phosphorylation of STAT3 and the dual Thr/Tyr phosphorylation of ERK, suggesting that the cAMP-mediated accumulation of SOCS-3 is sufficient to suppress JAK-STAT pathway activation by this receptor. Further characterisation of the response demonstrated that SOCS-3 induction could not be blocked by H89, an inhibitor of cAMP-dependent protein kinase (PKA), suggesting that a PKA independent mechanism was responsible. Consistent with this hypothesis, selective activation of PKA with the selective cAMP analogue 6Be-cAMP failed to promote SOCS-3 accumulation. Surprisingly, selective activation of \"Exchange protein activated by cAMP\" (Epac), a recently identified PKA-independent intracellular sensor of cAMP, using the cAMP analogue 8pCPT- 20Me-cAMP also failed to promote SOCS-3 accumulation. Moreover, the inability of both 6Be-cAMP and 8pCPT-20Me-cAMP to promote SOCS-3 accumulation was not due to a lack of biological activity, since both were able to stimulate the phosphorylation of ERK in U937 cells at the concentrations used to assess SOCS-3 induction. Finally, preliminary experiments employing inhibitors of various signalling pathways revealed that cAMP-mediated SOCS-3 accumulation occurred via a JAK-, p38- and ERK-independent mechanism. Thus, it is proposed that cAMP elevation may promote the accumulation of SOCS-3 in U937 cells via a novel pathway leading to increased SOCS-3 synthesis that is independent of the known cAMP sensors PKA and Epac, and which may thus involve a currently unknown intracellular sensor of cAMP.","abstract_html":"Suppressors of cytokine signalling (SOCS) protein induction via the &quot;Janus kinase- signal transducer and activator of transcription&quot; (JAK-STAT) pathway has been shown to be a critical negative feedback mechanism that prevents inappropriately sustained signalling from activated cytokine receptors. It also provides a mechanism by which other signalling modules could potentially regulate the JAK-STAT pathway. In this study, I have demonstrated that elevation of the prototypical second messenger cyclic AMP (cAMP) is capable of promoting the time- and concentration-dependent accumulation of the SOCS-3 isoform in U937 human promyeloid cells and HL60 human promyoblast cells. Experiments with MG132 demonstrated that cAMP specifically promoted SOCS-3 synthesis rather than blocking its degradation by the proteasome. The accumulation of SOCS-3 in U937 cells correlated with a reduced ability of the granulocyte-colony stimulating factor (G-CSF) receptor, which is a bona fide target for SOCS-3 in vivo, to promote the Tyr phosphorylation of STAT3 and the dual Thr/Tyr phosphorylation of ERK, suggesting that the cAMP-mediated accumulation of SOCS-3 is sufficient to suppress JAK-STAT pathway activation by this receptor. Further characterisation of the response demonstrated that SOCS-3 induction could not be blocked by H89, an inhibitor of cAMP-dependent protein kinase (PKA), suggesting that a PKA independent mechanism was responsible. Consistent with this hypothesis, selective activation of PKA with the selective cAMP analogue 6Be-cAMP failed to promote SOCS-3 accumulation. Surprisingly, selective activation of &quot;Exchange protein activated by cAMP&quot; (Epac), a recently identified PKA-independent intracellular sensor of cAMP, using the cAMP analogue 8pCPT- 20Me-cAMP also failed to promote SOCS-3 accumulation. Moreover, the inability of both 6Be-cAMP and 8pCPT-20Me-cAMP to promote SOCS-3 accumulation was not due to a lack of biological activity, since both were able to stimulate the phosphorylation of ERK in U937 cells at the concentrations used to assess SOCS-3 induction. Finally, preliminary experiments employing inhibitors of various signalling pathways revealed that cAMP-mediated SOCS-3 accumulation occurred via a JAK-, p38- and ERK-independent mechanism. Thus, it is proposed that cAMP elevation may promote the accumulation of SOCS-3 in U937 cells via a novel pathway leading to increased SOCS-3 synthesis that is independent of the known cAMP sensors PKA and Epac, and which may thus involve a currently unknown intracellular sensor of cAMP.","abstract_has_math":false,"creators":["Mullen, Laura Catherine"],"institution":"University of Glasgow","degree_name":null,"degree_level":"MSc(R)","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2006,"date_issued":"2006","date_published":"2006","updated_at":"2026-11-19T08:26:04Z","subjects":["QR180 Immunology"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.5525/gla.thesis.9058","outbound_label":"DOI","outbound_source":"dc:identifier.doi","record_url":"https://doi.org/10.5525/gla.thesis.9058","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier.doi","download_url":"https://theses.gla.ac.uk/9058/1/2006MullenMSc%28R%29.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A9058","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Mullen, Laura Catherine"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2006"]},{"key":"dc:date.issued","label":"Date","values":["2006"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Faculty of Biomedical & Life Sciences."]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/9058/"]},{"key":"dc:relation.isreferencedby.uri","label":"Dc Relation Isreferencedby URI","values":["https://gla.on.worldcat.org/oclc/1547400206"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["MSc(R)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR180 Immunology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.5525/gla.thesis.9058"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/9058/1/2006MullenMSc%28R%29.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Suppressors of cytokine signalling (SOCS) protein induction via the \"Janus kinase- signal transducer and activator of transcription\" (JAK-STAT) pathway has been shown to be a critical negative feedback mechanism that prevents inappropriately sustained signalling from activated cytokine receptors. It also provides a mechanism by which other signalling modules could potentially regulate the JAK-STAT pathway. In this study, I have demonstrated that elevation of the prototypical second messenger cyclic AMP (cAMP) is capable of promoting the time- and concentration-dependent accumulation of the SOCS-3 isoform in U937 human promyeloid cells and HL60 human promyoblast cells. Experiments with MG132 demonstrated that cAMP specifically promoted SOCS-3 synthesis rather than blocking its degradation by the proteasome. The accumulation of SOCS-3 in U937 cells correlated with a reduced ability of the granulocyte-colony stimulating factor (G-CSF) receptor, which is a bona fide target for SOCS-3 in vivo, to promote the Tyr phosphorylation of STAT3 and the dual Thr/Tyr phosphorylation of ERK, suggesting that the cAMP-mediated accumulation of SOCS-3 is sufficient to suppress JAK-STAT pathway activation by this receptor. Further characterisation of the response demonstrated that SOCS-3 induction could not be blocked by H89, an inhibitor of cAMP-dependent protein kinase (PKA), suggesting that a PKA independent mechanism was responsible. Consistent with this hypothesis, selective activation of PKA with the selective cAMP analogue 6Be-cAMP failed to promote SOCS-3 accumulation. Surprisingly, selective activation of \"Exchange protein activated by cAMP\" (Epac), a recently identified PKA-independent intracellular sensor of cAMP, using the cAMP analogue 8pCPT- 20Me-cAMP also failed to promote SOCS-3 accumulation. Moreover, the inability of both 6Be-cAMP and 8pCPT-20Me-cAMP to promote SOCS-3 accumulation was not due to a lack of biological activity, since both were able to stimulate the phosphorylation of ERK in U937 cells at the concentrations used to assess SOCS-3 induction. Finally, preliminary experiments employing inhibitors of various signalling pathways revealed that cAMP-mediated SOCS-3 accumulation occurred via a JAK-, p38- and ERK-independent mechanism. Thus, it is proposed that cAMP elevation may promote the accumulation of SOCS-3 in U937 cells via a novel pathway leading to increased SOCS-3 synthesis that is independent of the known cAMP sensors PKA and Epac, and which may thus involve a currently unknown intracellular sensor of cAMP."]},{"key":"dc:format","label":"Dc Format","values":["pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Regulation of suppressor of cytokine signalling-3 expression by cyclic-AMP in pro-myeloid cells"]}]}],"canonical_facts":{"dc:creator":["Mullen, Laura Catherine"],"dc:date":["2006"],"dc:date.issued":["2006"],"dc:description.abstract":["Suppressors of cytokine signalling (SOCS) protein induction via the \"Janus kinase- signal transducer and activator of transcription\" (JAK-STAT) pathway has been shown to be a critical negative feedback mechanism that prevents inappropriately sustained signalling from activated cytokine receptors. It also provides a mechanism by which other signalling modules could potentially regulate the JAK-STAT pathway. In this study, I have demonstrated that elevation of the prototypical second messenger cyclic AMP (cAMP) is capable of promoting the time- and concentration-dependent accumulation of the SOCS-3 isoform in U937 human promyeloid cells and HL60 human promyoblast cells. Experiments with MG132 demonstrated that cAMP specifically promoted SOCS-3 synthesis rather than blocking its degradation by the proteasome. The accumulation of SOCS-3 in U937 cells correlated with a reduced ability of the granulocyte-colony stimulating factor (G-CSF) receptor, which is a bona fide target for SOCS-3 in vivo, to promote the Tyr phosphorylation of STAT3 and the dual Thr/Tyr phosphorylation of ERK, suggesting that the cAMP-mediated accumulation of SOCS-3 is sufficient to suppress JAK-STAT pathway activation by this receptor. Further characterisation of the response demonstrated that SOCS-3 induction could not be blocked by H89, an inhibitor of cAMP-dependent protein kinase (PKA), suggesting that a PKA independent mechanism was responsible. Consistent with this hypothesis, selective activation of PKA with the selective cAMP analogue 6Be-cAMP failed to promote SOCS-3 accumulation. Surprisingly, selective activation of \"Exchange protein activated by cAMP\" (Epac), a recently identified PKA-independent intracellular sensor of cAMP, using the cAMP analogue 8pCPT- 20Me-cAMP also failed to promote SOCS-3 accumulation. Moreover, the inability of both 6Be-cAMP and 8pCPT-20Me-cAMP to promote SOCS-3 accumulation was not due to a lack of biological activity, since both were able to stimulate the phosphorylation of ERK in U937 cells at the concentrations used to assess SOCS-3 induction. Finally, preliminary experiments employing inhibitors of various signalling pathways revealed that cAMP-mediated SOCS-3 accumulation occurred via a JAK-, p38- and ERK-independent mechanism. Thus, it is proposed that cAMP elevation may promote the accumulation of SOCS-3 in U937 cells via a novel pathway leading to increased SOCS-3 synthesis that is independent of the known cAMP sensors PKA and Epac, and which may thus involve a currently unknown intracellular sensor of cAMP."],"dc:format":["pdf"],"dc:identifier.doi":["10.5525/gla.thesis.9058"],"dc:identifier.uri":["https://theses.gla.ac.uk/9058/1/2006MullenMSc%28R%29.pdf"],"dc:language":["en"],"dc:publisher.department":["Faculty of Biomedical & Life Sciences."],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/9058/"],"dc:relation.isreferencedby.uri":["https://gla.on.worldcat.org/oclc/1547400206"],"dc:subject":["QR180 Immunology"],"dcterms:accessrights":["public"],"dc:title":["Regulation of suppressor of cytokine signalling-3 expression by cyclic-AMP in pro-myeloid cells"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["MSc(R)"]},"updated_at":"2026-11-19T08:26:04Z"}